skip to content »


Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Journal Publications by EMG Members

Click on the Expand plus sign sign to list the journal publications by year. Then click on the PubMed link for details of that publication.

Time Line

Expand All


Collapse All | Expand All


  • Kubik M, Robles L, Kung D. Familial Bell's palsy: a case report and literature review. Case Report Neurol Med. 2012;2012:674981. [view publication]


Collapse All | Expand All


  • Killian JM, Smyth S, Guerra R, Adhikari I, Harati Y. Comparison of sudomotor and sensory nerve testing in painful sensory neuropathies. J Clin Neuromuscul Dis. 2011;12(3):138-42. [view publication]
  • Kung DH, Hubenthal EA, Kwan JY, Shelburne SA, Goodman JC, Kass JS. Toxoplasmosis myelopathy and myopathy in an AIDS patient: a case of immune reconstitution inflammatory syndrome? Neurologist. 2011;17(1):49-51. [view publication]
  • Kung DH, Qiu C, Kass JS. Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor. Psychosomatics. 2011;52(1):82-5. [view publication]
  • Manyam SC, Kung DH, Rhodes LB, Newmark ME, Friedman DE. Unilateral opercular lesion and eating-induced seizures. Epileptic Disord. 2010;12(4):309-13. [view publication]
  • Nunez-Wallace KR, Gill CE, Harrison CH, Taylor HM, Charles PD. Discordance in informed consent response on the basis of demographic factors: brief report. Intellect Dev Disabil. 2010;48(3):175-9. [view publication]
  • Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, et al. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Eur J Immunol. 2009;39(9):2525-36. [view publication]
  • Friedman DE, Kung DH, Laowattana S, Kass JS, Hrachovy RA, Levin HS. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure. 2009;18(6):429-33. [view publication]
  • Hong J, Li H, Chen M, Zang YC, Skinner SM, Killian JM, et al. Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis. Int Immunol. 2009;21(12):1329-40. [view publication]
  • Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol. 2004;172(8):5120-7. [view publication]
  • Smith RG, Roher AE, Appel SH, Doody RS, Killian JM, Corey-Bloom J, et al. Autonomic sudomotor dysfunction in Alzheimer's disease. Curr Med Chem - Imun Endoc Metab Agents. 2003;3(1):77-84. [view publication]
  • Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells. Int Immunol. 2003;15(9):1073-80. [view publication]
  • Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol. 2002;76(12):6147-54. [view publication]
  • Zhang JZ, Rivera VM, Tejada-Simon MV, Yang D, Hong J, Li S, et al. T cell vaccination in multiple sclerosis: results of a preliminary study. J Neurol. 2002;249(2):212-8. [view publication]
  • Killian JM, Foreman PJ. Clinical utility of dorsal sural nerve conduction studies. Muscle Nerve. 2001;24(6):817-20. [view publication]
  • Hong J, Zang YC, Tejada-Simon MV, Li S, Rivera VM, Killian J, et al. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol. 2000;165(12):6858-64. [view publication]
  • Tejada-Simon MV, Zang YC, Yang D, Hong J, Li S, Singh RA, et al. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol. 2000;12(12):1641-50. [view publication]
  • Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol. 2000;164(8):4011-7. [view publication]
  • Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, et al. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol. 2000;30(3):908-13. [view publication]
  • Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, et al. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol. 1999;163(6):3530-8. [view publication]
  • Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM, et al. Interferon beta induces T-helper 2 immune deviation in MS. Neurology. 1999;53(8):1692-7. [view publication]
  • Zang YC, Kozovska MM, Hong J, Li S, Mann S, Killian JM, et al. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol. 1999;29(5):1692-700. [view publication]
  • Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, Killian J, et al. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet. 1996;62(3):247-54. [view publication]
  • Killian JM, Tiwari PS, Jacobson S, Jackson RD, Lupski JR. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve. 1996;19(1):74-8. [view publication]
  • Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, et al. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 1996;17(3):451-60. [view publication]
  • Killian JM, Wilfong AA, Burnett L, Appel SH, Boland D. Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve. 1994;17(7):747-54. [view publication]
  • Roa BB, Garcia CA, Pentao L, Killian JM, Trask BJ, Suter U, et al. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet. 1993;5(2):189-94. [view publication]
  • Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66(2):219-32. [view publication]
  • Engelhardt JI, Appel SH, Killian JM. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease. J Neuroimmunol. 1990;27(1):21-31. [view publication]
  • Engelhardt JI, Appel SH, Killian JM. Experimental autoimmune motoneuron disease. Ann Neurol. 1989;26(3):368-76. [view publication]
  • Hayman LA, Taber KH, Jhingran SG, Killian JM, Carroll RG. Cerebral infarction: diagnosis and assessment of prognosis by using 123IMP-SPECT and CT. AJNR Am J Neuroradiol. 1989;10(3):557-62. [view publication]
  • Ammenheuser MM, Ward JB, Jr, Whorton EB, Jr, Killian JM, et al. Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. Mutat Res. 1988;204(3):509-20. [view publication]
  • Killian JM, Bressler RB, Armstrong RM, Huston DP. Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch Neurol. 1988;45(1):27-30. [view publication]
  • Spitz MC, Jankovic J, Killian JM. Familial tic disorder, parkinsonism, motor neuron disease, and acanthocytosis: a new syndrome. Neurology. 1985;35(3):366-70. [view publication]
  • Killian JM, Kloepfer HW. Homozygous expression of a dominant gene for Charcot-Marie-Tooth neuropathy. Ann Neurol. 1979;5(6):515-22. [view publication]
  • Alpert JN, Armbrust CA, Akhavi M, Stamatiou ES, Killian JM, De Shazo M. Glossopharyngeal neuralgia, asystole, and seizures. Arch Neurol. 1977;34(4):233-5. [view publication]
  • Killian JM, Fromm GH. A double-blind comparison of nitrazepam versus diazepam in myoclonic seizure disorders. Dev Med Child Neurol. 1971;13(1):32-9. [view publication]
  • Killian JM. Tegretol in trigeminal neuralgia with special reference to hematopoietic side effects. Headache. 1969;9(1):58-63. [view publication]
  • Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol. 1968;19(2):129-36. [view publication]
  • Fromm GH, Killian JM, Sanchez F, Jr. Observations on the discrepancy between the clinical and the laboratory effects of anti-petit mal drugs. Trans Am Neurol Assoc. 1967;92:238-40. [view publication]
  • Fromm GH, Killian JM. Effect of some anticonvulsant drugs on the spinal trigeminal nucleus. Neurology. 1967;17(3):275-80. [view publication]

E-mail this page to a friend